BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30
• 31

• 

  Drug Development

  The Second Wave: Biopharma Players Race to Develop Therapeutics for COVID-19

  Biopharmaceutical companies across the world are fighting an increasingly important battle against COVID-19: the struggle to treat the disease.

  December 16, 2021

   · 

  7 min read

   · 

  Kaylei Whalen
• 

  Drug Development

  Biogen Preps for Post-Approval Testing of Controversial Alzheimer’s Drug

  Biogen and Eisai released an update on the Phase IV post-marketing confirmatory study and plan to submit the final protocol to the FDA in March 2022 and launch patient screening in May 2022.

  December 16, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Horizon Forges Autoimmune Disease Collaboration Valued at $1.5 Billion

  The agreement between the two companies includes a lead, potential first-in-class preclinical candidate, and research collaboration to jointly develop the additional novel candidates.

  December 16, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Trial Touts 81% Response Rate in Locally Advance Breast Cancer

  Researchers have published a study describing how chemotherapy and a drug used to treat cardiac failure is able to regress tumor growth of patients with triple negative breast cancer.

  December 16, 2021

   · 

  2 min read

   · 

  Mark Terry
• 

  Drug Development

  Two Biotechs Uncloak to Deliver Affordable Biological Tools and Fight Dry Eye Disease

  Nodexus and Aramis Biosciences will use their funds to expand their company’s pipeline and build their commercialization capabilities.

  December 16, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  New Non-Profit Snags Three Big Name Research Partnerships

  Arc begins its mission with $650 million in donations from donors. This funding will sustain the scientists and their researchers over renewable eight-year terms.

  December 16, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Approved U.S. COVID-19 Vaccines Comparison Table

  The avalanche of news released every day about all three - or various combinations thereof - can be overwhelming. So, BioSpace has put together a chart for easy comparative reference.

  December 16, 2021

   · 

  2 min read
• 

  Biotech Beach

  How Pharma and Academia are Tackling the Opioid Epidemic

  Deaths from drug overdoses have been on an upward trajectory for years, but have experienced a notable increase since the early days of the COVID-19 pandemic.

  December 16, 2021

   · 

  5 min read

   · 

  Gail Dutton
• 

  BioMidwest

  Research Roundup: Hormone Identified that Drives Diabetes and More

  A recent study identified a hormone that may drive both type 1 and type 2 diabetes. For that and more research stories, read on.

  December 16, 2021

   · 

  5 min read

   · 

  Mark Terry
• 

  Biotech Bay

  Verge Will Leverage $98 Million to Validate Platform in the Clinic

  The new funding will allow the biotech company to advance its programs and accelerate the development of life-saving treatments for neurodegenerative diseases.

  December 16, 2021

   · 

  2 min read

   · 

  Alvin Clavines